SkinCancer360

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy
Featured image for “Checkpoint Therapeutics Receives Approval for PD-L1 Therapy”

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy

December 16, 2024
The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
Featured image for “Concerned About Skin Cancer? Here’s What You Should be Asking Your Dermatologist”

Concerned About Skin Cancer? Here’s What You Should be Asking Your Dermatologist

December 5, 2023
Your skin is your body’s first line of defense. Taking care of it is essential, especially when it comes to…
[wpb_childpages]

Recent Posts

Featured image for “A Mohs Surgeon Explains the Procedure”
Feb. 25, 2025

A Mohs Surgeon Explains the Procedure

Featured image for “Checkpoint Therapeutics Receives Approval for PD-L1 Therapy”
Dec. 16, 2024

Checkpoint Therapeutics Receives Approval for PD-L1 Therapy

Featured image for “Active Military Service Veterans are at Risk for Skin Cancers”
Dec. 03, 2024

Active Military Service Veterans are at Risk for Skin Cancers

Featured image for “Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure”
Nov. 05, 2024

Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure

Featured image for “Social Awareness and Support Needed for Spouses of Patients Recently Diagnosed With Cancer”
Sep. 24, 2024

Social Awareness and Support Needed for Spouses of Patients Recently Diagnosed With Cancer

Post Categories